Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood|February 5, 2020
Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in miceZoltan Nagy, Jun Mori, Vanesa-Sindi Ivanova, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 21, 2023
Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life Experience with 74 CasesVanesa-Sindi Ivanova, Visar Vela, Stefan Dirnhofer, et al.
Annals of Hematology|November 12, 2025
Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and OutcomesEva Erzar, Vanesa Sindi-Ivanova, Stefan Dirnhofer, et al.
The American Journal of Surgical Pathology|June 12, 2024
The Genetic Landscape of Primary Breast Marginal Zone Lymphoma Identifies a Mutational-driven Disease With Similarities to Ocular Adnexal LymphomaVanesa-Sindi Ivanova, Thomas Menter, Joel Zaino, et al.
Histopathology|November 15, 2023
Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosisVanesa-Sindi Ivanova, John Davies, Thomas Menter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 11, 2025
Exploring the Genetic Landscape of Primary Marginal Zone Lymphoma of the Urinary BladderIlaria Balestri, Vanesa-Sindi Ivanova, Gorana Gašljević, et al.
British Journal of Haematology|January 8, 2025
Distinct subtypes of post-transplant lymphoproliferative disorders: CHIP-like mutations in early lesions and substantial mutational differences between EBV-positive and EBV-negative diffuse large B-cell lymphomasVanesa-Sindi Ivanova, Thomas Menter, Ningxuan Cui, et al.
Blood Cancer Journal|April 16, 2025
PDL1-expressing macrophages infiltrate diffuse large B-cell lymphoma and promote lymphoma growth in a MYC-driven experimental modelNingxuan Cui, Peter Leary, Vanesa-Sindi Ivanova, et al.
Eclinicalmedicine|October 2, 2023
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)Urban Novak, Martin Fehr, Sämi Schär, et al.
Blood Advances|July 5, 2024
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in miceChristopher W Smith, Joana Campos, Helena C Brown, et al.
Pageof 1